Radiance 330-C (proton therapy system)

2024: Product Announcement

On September 27, 2024, ProTom International introduced the Radiance 330-C vertical proton therapy system. The complex is intended for treatment of various types of malignancies.

Proton therapy facilities use a beam of high-energy protons to irradiate diseased tissue. The principle of operation of such systems is the selective destruction of cancer structures as a result of the interaction of ionizing particles with matter inside cells.

𝓲

Prnewswire.com

The installation of Radiance 330-C is said to dramatically change the approach to treating malignancies. The system integrates with Leo Cancer Care Marie's patient vertical positioning and imaging platform, making proton therapy more accessible to facilities with limited budget and free space to install equipment. Radiance 330-C occupies relatively little space, allowing for separate or multifunctional facilities within or adjacent to the existing radiation oncology department. The system offers many configurations that can be adapted to any space constraints.

The new complex is equipped with Fidelity pencil beam scanning technology. The pointed beam of protons moves along the vertical and horizontal axes, like the tip of a pencil "shading" the entire tumor. Such a method is effective in the treatment of the most complex oncological diseases, such as tumors of the prostate, brain, eye, etc. A stationary beam feed system improves reliability and accuracy while reducing maintenance costs. The unit includes a compact synchrotron particle accelerator that provides a clinical treatment energy range of 70 MeV to 250 MeV.^[1]

Notes